MENU
+Compare
APGE
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$47.67
Change
+$0.65 (+1.38%)
Capitalization
2.71B

APGE Apogee Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for APGE with price predictions
Dec 20, 2024

APGE's RSI Indicator recovers from oversold territory

The RSI Oscillator for APGE moved out of oversold territory on November 25, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 4 similar instances when the indicator left oversold territory. In of the 4 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 14 cases where APGE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for APGE just turned positive on December 04, 2024. Looking at past instances where APGE's MACD turned positive, the stock continued to rise in of 10 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where APGE advanced for three days, in of 88 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 18, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on APGE as a result. In of 18 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for APGE crossed bearishly below the 50-day moving average on November 19, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APGE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

APGE broke above its upper Bollinger Band on December 04, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for APGE entered a downward trend on December 19, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. APGE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.697) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). APGE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (256.215).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APGE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

APGE is expected to report earnings to fall 28.17% to -62 cents per share on March 11

Apogee Therapeutics APGE Stock Earnings Reports
Q4'24
Est.
$-0.62
Q3'24
Missed
by $0.30
Q2'24
Missed
by $0.08
Q1'24
Missed
by $0.15
Q4'23
Missed
by $0.15
The last earnings report on November 13 showed earnings per share of -86 cents, missing the estimate of -56 cents. With 606.24K shares outstanding, the current market capitalization sits at 2.71B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
221 Crescent Street
Phone
+1 650 394-5230
Employees
91
Web
https://www.apogeetherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HMVRX16.810.20
+1.20%
Hartford MidCap Value R3
CHASX14.440.16
+1.12%
Chase Growth N
SCSCX63.810.67
+1.06%
Touchstone Large Cap Focused C
CAFFX42.960.42
+0.99%
American Funds AMCAP 529F1
TBDQX19.350.13
+0.68%
PGIM Jennison Diversified Growth R6

APGE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+1.47%
SYRE - APGE
44%
Loosely correlated
+3.16%
BHVN - APGE
43%
Loosely correlated
+2.60%
ACLX - APGE
38%
Loosely correlated
+0.44%
ALLO - APGE
38%
Loosely correlated
+1.63%
IMNM - APGE
35%
Loosely correlated
-0.99%
More